Trigeminal Neuralgia is a chronic condition that affects the trigeminal nerve. This nerve is responsible for transmitting sensations from the face to the brain and spreads across the cheeks ...

Some neurosurgeons advocate for an operation sooner, with the goal of preventing further damage to the trigeminal nerve from unrelieved neurovascular contact. It is unknown whether early versus ...

Atypical trigeminal neuralgia (ATN) is a chronic pain condition characterized by persistent facial pain that does not respond ...

Noninvasive therapy seeks to enhance focus and behavior by gently stimulating a nerve associated with attention and executive ...

Atypical trigeminal neuralgia (ATN) is a chronic pain condition characterized by persistent facial pain that does not respond well to conventional medical treatments, often leading to significant ...

NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

Researchers at UCLA Health are launching the first clinical trial to test whether a wearable device that delivers gentle nerve stimulation during sleep could ease ADHD symptoms in children with ...

NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.

The correlation between trigeminal nerve-root section and the appearance ... The appearance of herpes lesions in patients in whom motor function was preserved makes it unlikely that motor-nerve ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on Wednesday, earlier than previously guided. NeuroOne Medical is ...